TRHC Stock Overview
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Tabula Rasa HealthCare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.16 |
| 52 Week High | US$6.69 |
| 52 Week Low | US$2.09 |
| Beta | 1.54 |
| 1 Month Change | -18.87% |
| 3 Month Change | 12.91% |
| 1 Year Change | -8.83% |
| 3 Year Change | -90.27% |
| 5 Year Change | -86.70% |
| Change since IPO | -65.32% |
Recent News & Updates
Recent updates
Continuing To Avoid Tabula Rasa HealthCare Inc.
May 19Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?
May 11
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Feb 09Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)
Jan 19Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching
Dec 06Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?
Nov 05Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price
Jul 26Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Jun 28We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed
Jun 05Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price
Apr 02Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt
Mar 12Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years
Feb 19Is Now The Time To Look At Buying Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
Jan 29
Tabula Rasa HealthCare rallies on FY20 revenue to top consensus mark
Jan 12Tabula Rasa HealthCare partners to provide pharmacy benefit services across California
Jan 11This Insider Has Just Sold Shares In Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)
Jan 08Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 95% Above Its Share Price
Dec 29Tabula Rasa HealthCare's DoseMeRx partners with Physiomics
Dec 17Shareholder Returns
| TRHC | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -9.9% | -1.4% | -0.3% |
| 1Y | -8.8% | -27.8% | -14.8% |
Return vs Industry: TRHC exceeded the US Healthcare Services industry which returned -27.2% over the past year.
Return vs Market: TRHC exceeded the US Market which returned -14.2% over the past year.
Price Volatility
| TRHC volatility | |
|---|---|
| TRHC Average Weekly Movement | 9.3% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TRHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: TRHC's weekly volatility has decreased from 16% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,027 | Brian Adams | https://www.tabularasahealthcare.com |
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention.
Tabula Rasa HealthCare, Inc. Fundamentals Summary
| TRHC fundamental statistics | |
|---|---|
| Market Cap | US$126.77m |
| Earnings (TTM) | -US$77.33m |
| Revenue (TTM) | US$299.52m |
0.4x
P/S Ratio-1.6x
P/E RatioIs TRHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRHC income statement (TTM) | |
|---|---|
| Revenue | US$299.52m |
| Cost of Revenue | US$232.60m |
| Gross Profit | US$66.91m |
| Other Expenses | US$144.25m |
| Earnings | -US$77.33m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.15 |
| Gross Margin | 22.34% |
| Net Profit Margin | -25.82% |
| Debt/Equity Ratio | -572.9% |
How did TRHC perform over the long term?
See historical performance and comparison